Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 6:4:575-590.
doi: 10.1016/j.trci.2018.06.014. eCollection 2018.

Inflammation as a central mechanism in Alzheimer's disease

Jefferson W Kinney  1 , Shane M Bemiller  2 , Andrew S Murtishaw  1 , Amanda M Leisgang  1 , Arnold M Salazar  1 , Bruce T Lamb  2
Affiliations
Review

Inflammation as a central mechanism in Alzheimer's disease

Jefferson W Kinney et al. Alzheimers Dement (N Y). .

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by cognitive decline and the presence of two core pathologies, amyloid β plaques and neurofibrillary tangles. Over the last decade, the presence of a sustained immune response in the brain has emerged as a third core pathology in AD. The sustained activation of the brain's resident macrophages (microglia) and other immune cells has been demonstrated to exacerbate both amyloid and tau pathology and may serve as a link in the pathogenesis of the disorder. In the following review, we provide an overview of inflammation in AD and a detailed coverage of a number of microglia-related signaling mechanisms that have been implicated in AD. Additional information on microglia signaling and a number of cytokines in AD are also reviewed. We also review the potential connection of risk factors for AD and how they may be related to inflammatory mechanisms.

Keywords: Alzheimer's disease; Cytokines; Inflammation; Microglia; Microglia receptors.

PubMed Disclaimer

References

    1. Prince M., Comas-Herrera A., Knapp M., Guerchet M., Karagiannidou M. Alzheimer's Disease International; London: 2016. World Alzheimer Report 2016: Improving Healthcare for People Living With Dementia: Coverage, Quality and Costs Now and in the Future.
    1. Hebert L.E., Weuve J., Scherr P.A., Evans D.A. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology. 2013;80:1778–1783. - PMC - PubMed
    1. Alzheimer's Impact Movement . Alzheimer's Association; Chicago, IL: 2017. Alzheimer's Disease Caregivers Factsheet.
    1. Selkoe D.J. Normal and abnormal biology of the beta-Amyloid Precursor Protein. Annu Rev Neurosci. 1994;17:489–517. - PubMed
    1. O'Brien R.J., Wong P.C. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci. 2011;34:185–204. - PMC - PubMed